NANO Nuclear Energy Secures Landmark AFWERX Contract for KRONOS Micro Reactor Development
Share- Nishadil
- September 03, 2025
- 0 Comments
- 2 minutes read
- 6 Views

NANO Nuclear Energy Inc. (NASDAQ: NNE), a company at the forefront of advanced nuclear energy, has proudly announced a significant milestone: the award of a prestigious AFWERX Direct to Phase II Small Business Innovation Research (SBIR) contract. This pivotal contract will accelerate the Research, Development, Test, and Evaluation (RDT&E) of the company’s cutting-edge KRONOS Micro Modular Reactor (MMR) at the highly strategic Joint Base Anacostia-Bolling (JBAB) in Washington D.C.
This Direct to Phase II award is a powerful testament to the U.S.
Air Force's confidence in NANO Nuclear's innovative approach and the KRONOS MMR's potential. It signifies a critical leap forward, bypassing the initial feasibility study phase and moving directly into active development, underscoring the urgency and strategic importance of advanced microreactor technology for national security and energy resilience.
The KRONOS MMR is designed to deliver a robust, reliable, and carbon-free energy source, ideally suited for demanding environments.
Its compact and modular nature makes it perfect for deployment in remote military bases, critical infrastructure, and disaster relief scenarios, offering unparalleled energy independence and resilience. For the Department of Defense (DoD), this means enhanced operational capabilities, reduced reliance on vulnerable fuel supply chains, and a significant step towards a more sustainable energy future.
Jay Jiang Yu, Founder, Chairman, and CEO of NANO Nuclear Energy Inc., emphasized the profound implications of this contract: “This AFWERX Direct to Phase II contract is not just an award; it’s a validation of our vision and the hard work of our incredible team.
It accelerates the development of KRONOS, bringing us closer to providing a secure, reliable, and emission-free power source for critical national defense infrastructure. This positions NANO Nuclear Energy as a vital partner in enhancing the energy resilience and grid independence of our armed forces.”
Dr.
Jeffrey Latkowski, Chief Reactor Officer of NANO Nuclear Energy Inc., highlighted the technical significance: “The KRONOS microreactor represents a paradigm shift in energy deployment. This contract enables us to rigorously test and evaluate the KRONOS MMR in a real-world, high-stakes environment at Joint Base Anacostia-Bolling, proving its capabilities for the DoD.
We are incredibly excited to advance this groundbreaking technology, which will address critical energy needs and combat climate change.”
The deployment at JBAB is particularly strategic, providing a direct avenue for the U.S. Air Force and the broader DoD to evaluate the operational benefits of microreactors.
This includes ensuring uninterrupted power for essential installations, supporting critical national security missions, and significantly reducing the carbon footprint associated with traditional energy sources. The project also aligns with the U.S. Space Force’s vision for resilient and independent energy solutions.
Winston Chow, Chief Policy Officer of NANO Nuclear Energy Inc., underscored the broader policy impact: “This contract exemplifies a proactive approach by AFWERX to integrate cutting-edge energy solutions into our national defense strategy.
Microreactors like KRONOS are essential for ensuring energy security, bolstering grid independence, and empowering our military with reliable power in any situation. This initiative will pave the way for widespread adoption of advanced nuclear technologies across the federal sector.”
This landmark Direct to Phase II SBIR contract marks a pivotal moment for NANO Nuclear Energy, reinforcing its position as a leader in developing innovative nuclear solutions that promise to transform energy landscapes for both defense and civilian applications, securing a brighter, more resilient future.
.Disclaimer: This article was generated in part using artificial intelligence and may contain errors or omissions. The content is provided for informational purposes only and does not constitute professional advice. We makes no representations or warranties regarding its accuracy, completeness, or reliability. Readers are advised to verify the information independently before relying on